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ABSTRACT
Objective: The aim of the research about atenolol gel is to formulate and evaluate its stability in hydroxypropyl methylcellulose (HPMC) and Aqupec 
HV-505 gel base.
Methods: Gels were formulated using Acupev HV-505 and HPMC at three different concentrations. Physicochemical evaluation and stability testing 
were performed including organoleptic examination, pH, viscosity, consistency, bleeding, qualitative analysis by thin-layer chromatography (TLC), and 
quantitative analysis by UV-visible spectrophotometry during 56 days of storage.
Conclusions: About 1% Aqupec HV-505 provided good physical properties and physicochemical stability to be used as gel base.
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INTRODUCTION
Gels, as semisolid base for transdermal preparation, are a class of 
dosage form which have a higher aqueous component that permits 
greater dissolution of drugs and also permits easy migration of the 
drug through a vehicle that is essentially a liquid, compared with the 
ointment or cream base [8-11]. Kim and Shin developed and studied the 
release of atenolol from the ethylene-vinyl acetate matrix containing 
various plasticizers. Many other study also developed increased release 
from topical formulation [12-15]. Hence, the objectives of this study 
were to formulate and investigate the physicochemical stability of 
atenolol in two different gel bases. The influence of gelling agent, drug 
loading effect, and skin irritation studies were also evaluated.
MATERIALS AND METHODS
Materials
Atenolol (PT Kalbe Farma), Ammonia 21%, Aqupec HV-505 (Sumitomo 
Seika), Aquadest, DMDM hydantoin, Ethyl acetate, (hydroxypropyl 
methylcellulose [HPMC], Bratachem), Methanol (Bratachem), Nutrient 
Agar (Oxoid), Propylene glycol (Bratachem), and Triethanolamine 
(TEA, Bratachem) were used.
Atenolol content was determined by Spectrophotometry UV-visible 
(Specord 200). The pH was measured by pH-meter 744 Methrohm 




The composition of gel formulation is shown in Table 1. The HPMC was 
dispersed with continuous stirring until uniformly dispersed and the 
solution was allowed to cool to 50°C. The other ingredients were added 
with continuous stirring. Atenolol dissolved in propylene glycol was 
added slowly with stirring. Other ingredients were added slowly while 
stirring until homogenous gel was obtained.
Aqupec HV-505 gels
Aqupec HV-505 powder was dispersed in hot water and stirred with a 
stirrer at 2500 rpm, and the gels then were left overnight at ambient 
temperature. Triaethanol amine was added until the clear gel was 
obtained. Atenolol was dissolved in propylene glycol and was added 
slowly with stirring into solution; the other ingredients were added 
with continuous stirring.
Physical stability investigation
Parameters investigated including organoleptic and bleeding 
investigation, pH, and viscosity measurement.
Microbial investigation
This study was conducted to investigate the efficacy of DMDM hydantoin 
as the preservative after the gels were stored for 14 days. The study was 
conducted by counting method.
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Results: Physicochemical evaluation showed that the best formula was the one with 1% Aqupec HV-505 base (FA2). Further investigation
 was  conducted  by  varying  atenolol  concentration  to  study  the  influence  on  gel  stability.  Evaluation  on  organoleptic  performance,  pH,  viscosity, 
consistency, bleeding, microbiology, and qualitative and quantitative stability testing using TLC and UV-visible Spectrophotometry during 56 
days of storage showed that the best gel formula was FA22, the one using 1% Aqupec HV-505 with 0.5% Atenolol The patch test showed that all 
atenolol gels were safe to be used.
Atenolol is one of the β-selective adrenergic blocking agents in the 
treatment of angina pectoris. It is reported to have extensive hepatic 
first-pass effect after oral administration [1,2]. It is also very well 
known that conventional therapy such as orally, may result higher 
fluctuations in plasma concentration of the drug and unwanted 
side effect [3]. Hence, the transdermal drug delivery system that 
provides a predetermined constant drug delivery would be beneficial 
for effective and safe therapy [4]. Most of the transdermal delivery 
is formulated as topical preparations. The main advantage of this 
system is to overcome the first-pass metabolism. Other advantages 
of topical preparations are avoidance of the risks and inconveniences 
of intravenous therapy and reducing the effect of varied conditions 
on drug absorption, like pH changes, presence of enzymes, gastric 
emptying time are [5-7].
384
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 383-386
 Chaerunisaa et al. 
Qualitative and quantitative determination of atenolol in gel
Qualitative analysis was performed by thin-layer chromatography 
(TLC) into gel. Samples were dissolved in methanol and the eluent was 
ammonia:methanol (1:4). The spot was observed at UV light 254 nm.
Quantitative analysis was conducted by measuring the atenolol content 
in the sample. 1 g of gel was accurately weighed and placed in a 100 ml 
volumetric flask containing 30 ml of methanol, stirred for 30 min, 
and made up to volume. The amount of atenolol was calculated using 
standard obtained curve. The determination was conducted at 1st day 
and 56th day of preparation.
Safety test
The safety test was conducted into 10 volunteers using patch test 
method.
RESULTS AND DISCUSSION
Physical stability investigation of atenolol in Aqupec HV-505 and 
HPMC bases
Organoleptic investigation showed that all formulae have smooth texture, 
odorless, and spreadable. Gel with HPMC base was white opaque, while 
the one with Aqupec HV-505 was clear and transparent. The result was 
stable during 56 days of storage. Based on aesthetic considerations, 
Aqupec HV-0505 1% was best one for gel base. So it is used for next 
experiment to which variating the Atenolol concentration in gels.
pH of gels in various bases
Ideal pH for topical preparation is 5.5–10. The result showed that pH 
of FA was 7.58–7.80, and it means that all gels with Aqupec HV-505 and 
HPMC base fulfilled the pH requirement. The pH was decreased during 
56 days of storage, especially FB formulas, but they all still in required 
pH for topical preparation. pH of gels during storage is shown in Fig. 1.
Viscosity of gels
Investigation on gels’ viscosity gave the results that viscosity was 
decreased during the time of storage (Fig. 2). A decrease in viscosity 
may due to indirectly monitor chemical degradation because changes at 
the molecular level may cause changes in viscosity [16-18].
Further investigation was conducted by varying the atenolol 
concentration on 1% Aqupec HV 505. Based on organoleptic 
investigation, almost all gels were also clear, transparent, and well 
spreadable. Aqupec HV-505 1.5% became turbid, especially, after 0.5% 
atenolol was added. No bleeding happened in all gels during 56 days of 
storage. Formula used in gels with various concentration of atenolol is 
shown in Table 2.
Physical stability investigation of 1% Aqupec HV-505 gels with 
various concentration of atenolol
Organoleptic investigation
Based on the result of organoleptic investigation including color, smell, 
and consistency during 56 days of storage, it was concluded that FA2.0, 
FA2.1, FA2.2, and FA2.3 had homogenous and stable during the time of 
investigation at ambient temperature. The results show that there were 
no visible changes in the gel formulation.
pH of gel
Viscosity of gels
The viscosity of gels containing atenolol was lower compared with 
those without atenolol, which is due to internal and molecular change 
of atenolol addition. Furthermore, the results revealed that the increase 
of atenolol concentration in gel formulation did not affect the viscosity. 
Effect of time of storage was investigated for 56 days. The results 
Table 1: Formula of atenolol gel
Ingredients FA FB
FA1 FA2 FA3 FB1 FB2 FB3
HPMC (%) - - - 1.50 2.00 2.50
Aqupec HV-505 (%) 0.50 1.00 1.50 - - -
Atenolol (%) 0.50 0.50 0.50 0.50 0.50 0.50
TEA (%) 1.00 1.75 2.50 1.00 1.00 1.00
Propylene glycol (%) 25.00 25.00 25.00 25.00 25.00 25.00
Ethyl acetate (%) 5.00 5.00 5.00 5.00 5.00 5.00
DMDM hydantoin (%) 0.30 0.30 0.30 0.30 0.30 0.30
Aquadest ad (%) 100.00 100.00 100.00 100.00 100.00 100.00
FA: Formula gel using Aqupec HV-505, FA1: Formula gel using Aqupec 
HV-505 0.5%, FA2: Formula gel using Aqupec HV-505 1%, FA3: Formula gel 
using Aqupec HV-505 1.5%, FB: Formula gel using HPMC, FB1: Formula gel using 
HPMC 1.5%, FB2: Formula gel using HPMC2%, FB3: Formula gel using HPMC 2.5. 
TEA: Triethanolamine
Table 2: Formula of gel with various concentration of atenolol
Ingredients FA2.0 FA2.1 FA2.2 FA2.3
Aqupec HV-505 1(%) 1.00 1.00 1.00 1.00
Atenolol (%) - 0.50 1.00 1.50
TEA (%) 1.75 1.75 1.75 1.75
Propylene glycol (%) 25.00 25.00 25.00 25.00
Ethyl acetate (%) 5.00 5.00 5.00 5.00
DMDM hydantoin (%) 0.30 0.30 0.30 0.30
Aquadest ad (%) 100.00 100.00 100.00 100.00
FA2.0: Formula of Aqupec HV-505 1% gel without atenolol, FA2.1: Formula of 
Aqupec HV-505 1% gel with atenolol 0.5%, FA2.2: Formula of Aqupec HV-505 1% 
gel with atenolol 1.0%, FA2.3: Formula of Aqupec HV-505 1% gel with atenolol 
1.5%. TEA: Triethanolamine
Fig. 1: pH of atenolol gels in various bases
Fig. 2: The viscosity of each gel during the time of storage
The pH of FA2 was 7.74–8.30. Addition of atenolol causes an increase in
 pH. It may be caused by the physicochemical of Atenolol itself as weak
 base.  The  increase  in  the  concentration  of  atenolol  resulted  in 
bigger pH value of gels. The pH of gels with various concentration of 
atenolol is shown in Fig. 3.
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showed that gel formulation was stable after 56 days of storage. 
Viscosity of gels with various concentration of atenolol during the time 
of storage is shown in Fig. 4.
Microbial Investigation
The test was conducted to prove that preservative used in formulation 
was effective. It was found that there was no bacterial growth after 
14 days of investigation which can be concluded that the preservative is 
effectively worked in the gels.
Qualitative analysis by TLC
The purpose of the study was to investigate atenolol content in gels 
during the time of storage. First, the investigation was conducted by 
qualitative analysis using TLC method. Furthermore, the quantitative 
analysis was conducted to investigate the homogeneity content of 
atenolol in gel preparation. The study was performed into all gels at the 
day of preparation and after 56 days of storage. Qualitative analysis by 
TLC method showed that Rf of atenolol in gels and atenolol powder as 
standard were unchanged after formulation, as well as after 56 days of 
storage as shown in Table 3.
Quantitative analysis
Atenolol content in gels is shown in Fig. 5. From the results, it can 
be concluded that drug content in gels did not significantly changed 
during the time of storage. Stability of atenolol in gel formulation can 
be explained by inert matrix using as gel basis. HPMC and Carbopol as 
matrix used in gel basis revealed the stability for atenolol after 56 days 
of storage.
Safety test
Safety test was conducted by Patch test method to find out whether the 
formulation may be caused or aggravated by a contact allergy to the 
skin. Positive reactions were observed; skin reaction nearly becomes 
red and/or itchy. The safety test gave the result that all gels were save 
to be used because it did not give the allergic reaction to the volunteers.
CONCLUSIONS
Organoleptic investigation showed that all formulae have smooth 
texture, odorless, and spreadable. Gel with HPMC base was white 
opaque, while the one with Aqupec HV-505 were clear and transparent 
which was stable during 56 days of storage. Gels with Aqupec HV-
505 and HPMC base were fulfilled the pH requirement for topical 
preparation. Viscosity of FA and FB was decreased during the time 
of storage. The addition of atenolol concentration did not affect the 
viscosity significantly.
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